Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma

被引:5
作者
Wang, He [1 ]
Wang, Huiwen [1 ]
Cui, Wenyu [2 ]
Zhang, Qiao [2 ]
Li, Jing [2 ]
Zhang, Qi [2 ]
机构
[1] Harbin Med Univ, Dept Intervent, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Univ Commerce, Sch Pharm, 138 Tongda St, Harbin 150076, Heilongjiang, Peoples R China
关键词
MiR-889; Hepatocellular carcinoma; Prognosis; Proliferation; Migration; Invasion; POOR-PROGNOSIS; PROLIFERATION; CANCER; DIAGNOSIS; MICRORNAS; CONTRIBUTES; METASTASIS; SUPPRESSES; GROWTH; DAB2IP;
D O I
10.1186/s13000-021-01111-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background As a new type of molecular marker, microRNAs (miRNAs) can be used for early diagnosis and prognosis prediction of malignant tumors, and has broad clinical application prospects. This paper mainly studies the important role of miR-889 in the occurrence and development of hepatocellular carcinoma and the prognostic significance of miR-889 in hepatocellular carcinoma. Methods Quantitative real-time PCR analysis detected the expression levels of miR-889 in hepatocellular carcinoma tissues and cell lines. Kaplan-Meier curve and Cox regression analysis were used to explore the prognostic significance of miR-889 in hepatocellular carcinoma. The CCK-8 and Transwell assays assay were used to assess cell proliferation, migration, and invasion abilities ability. Results The expression of miR-889 in hepatocellular carcinoma tissues was significantly higher than that in adjacent tissues. Overexpression of miR-889 was significantly associated with TNM stage, hepatitis B virus infection, and cirrhosis. Patients with high miR-889 expression had shorter overall survival than those with low miR-889 expression. And functional studies in two hepatocellular carcinoma cell lines have shown that overexpression of miR-889 significantly promoted cell proliferation, migration, and invasion in vitro. Conclusions Overall, miR-889 was upregulated in hepatocellular carcinoma tissues and cell lines, and overexpression of miR-889 promoted cell proliferation, migration, and invasion in hepatocellular carcinoma cells. Based on our findings, high expression of miR-889 may promote the progression of hepatocellular carcinoma, and high expression of miR-889 is also forecasted for an unfavorable prognosis in hepatocellular carcinoma.
引用
收藏
页数:8
相关论文
共 40 条
[1]   MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer [J].
Bertoli, Gloria ;
Cava, Claudia ;
Castiglioni, Isabella .
THERANOSTICS, 2015, 5 (10) :1122-1143
[2]  
Chen DY, 2020, MICRORNA 889 INHIBIT, V11
[3]   High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma [J].
Dong, Bingwei ;
Zhang, Weibo .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (03) :129-134
[4]   MicroRNA-889 plays a suppressive role in cell proliferation and invasion by directly targeting TAB1 in non-small cell lung cancer [J].
Dong, Zheng ;
Li, Bingchun ;
Wang, Xiaojuan .
MOLECULAR MEDICINE REPORTS, 2019, 20 (01) :261-269
[5]   Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer [J].
Fang, Tian ;
Lv, Hongwei ;
Lv, Guishuai ;
Li, Ting ;
Wang, Changzheng ;
Han, Qin ;
Yu, Lexing ;
Su, Bo ;
Guo, Linna ;
Huang, Shanna ;
Cao, Dan ;
Tang, Liang ;
Tang, Shanhua ;
Wu, Mengchao ;
Yang, Wen ;
Wang, Hongyang .
NATURE COMMUNICATIONS, 2018, 9
[6]   Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression [J].
Ge, Dawei ;
Chen, Hongtao ;
Zheng, Shengnai ;
Zhang, Bin ;
Ge, Yingbin ;
Yang, Lei ;
Cao, Xiaojian .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
[7]   MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1 [J].
Ge, Xin ;
Gong, Liansheng .
TUMOR BIOLOGY, 2017, 39 (03) :1-8
[8]   MiR-889 promotes cell growth in human non-small cell lung cancer by regulating KLF9 [J].
Han, Xu ;
Tang, Yihu ;
Dai, Yawei ;
Hu, Shuai ;
Zhou, Jingxin ;
Liu, Xiang ;
Zhu, Jinfu ;
Wu, Yanhu .
GENE, 2019, 699 :94-101
[9]   The diagnosis and treatment of hepatocellular carcinoma [J].
Hartke, Justin ;
Johnson, Matthew ;
Ghabril, Marwan .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (02) :153-159
[10]   Immunotherapy of Hepatocellular Carcinoma [J].
Heinrich, Bernd ;
Czauderna, Carolin ;
Marquardt, Jens U. .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) :292-297